FBT

First Trust NYSE Arca Biotechnology Index Fund

Up$147.15
+$2.28
(+1.57%)
As of 7:30:00 PM EDT | 2/15/19  |  Market Closed

FBT Trading Data

Open

$145.68

Low Price

$145.27

High Price

$147.17

Previous Last Price

$144.87

Bid Size

$123.33 X 100

Ask Size

$148.19 X 500

FBT Portfolio Data

AUM

$2,831,035,200

Shares

19,550

PE Ratio

19.7

Price / Book Ratio

6.09

Expense Ratio

0.56

Net Asset Value

$144.81

Volume

Volume

120,785

Avg. Volume (YDT)

155,869

Dollar Volume

$14,955,171

Weekly Avg. Volume

98,240

Monthly Avg. Volume

138,515

Quarterly Avg. Volume

192,303

FBT Fund Description

The First Trust NYSE Arca Biotechnology Index Fund is and exchange-traded index fund. The investment objective of the fund is to replicate as closely as possible, before fees and expenses, the price and yield of the NYSE Arca Biotechnology Index. The NYSE Arca Biotechnology Index is an equal dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. Such processes include, but are not limited to, recombinant DNA technology, molecular biology, genetic engineering, monoclonal antibody-based technology, lipid/liposome technology, and genomics. The index is rebalanced quarterly based on closing prices on the third Friday in January, April, July and October to ensure that each component stock continues to represent approximately equal weight in the index.

FBT Chart

FBT Summary

Fund Family

First Trust Portfolios

Tracks This Index

First Trust NYSE Arca Biotechnology Index Fund

Inception Date

2006-06-19

Asset Class

Equity

Asset Class Size

Biotech

FBT Classification

Region (General)

Global

Region (Specific)

Sector

Health Care

Equity Index

Leveraged Family

FBT Holdings

Top 10 Holdings

Exelixis Inc. (EXEL)
4.75%
Ionis Pharmaceuticals Inc. (IONS)
4.31%
Intercept Pharmaceuticals Inc. (ICPT)
4.15%
Illumina Inc. (ILMN)
3.83%
Charles River Laboratories International Inc. (CRL)
3.76%
Alnylam Pharmaceuticals Inc. (ALNY)
3.7%
Incyte Corporation (INCY)
3.69%
Biogen Inc. (BIIB)
3.61%
Regeneron Pharmaceuticals Inc. (REGN)
3.6%
Grifols S.A. (ADR) (GRFS)
3.59%

Total FBT Holdings

Total Holdings: 31

Exelixis Inc. (EXEL)
4.75%
Ionis Pharmaceuticals Inc. (IONS)
4.31%
Intercept Pharmaceuticals Inc. (ICPT)
4.15%
Illumina Inc. (ILMN)
3.83%
Charles River Laboratories International Inc. (CRL)
3.76%
Alnylam Pharmaceuticals Inc. (ALNY)
3.7%
Incyte Corporation (INCY)
3.69%
Biogen Inc. (BIIB)
3.61%
Regeneron Pharmaceuticals Inc. (REGN)
3.6%
Grifols S.A. (ADR) (GRFS)
3.59%
Vertex Pharmaceuticals Incorporated (VRTX)
3.56%
QIAGEN N.V. (QGEN)
3.54%
Amgen Inc. (AMGN)
3.5%
IQVIA Holdings Inc. (IQV)
3.42%
BioMarin Pharmaceutical Inc. (BMRN)
3.32%
Gilead Sciences Inc. (GILD)
3.29%
United Therapeutics Corporation (UTHR)
3.23%
Alexion Pharmaceuticals Inc. (ALXN)
3.2%
bluebird bio Inc. (BLUE)
3.15%
Bio-Techne Corporation (TECH)
3.13%
Seattle Genetics Inc. (SGEN)
3.1%
Celgene Corporation (CELG)
3.04%
Alkermes Plc (ALKS)
3.01%
ACADIA Pharmaceuticals Inc. (ACAD)
2.93%
Agios Pharmaceuticals Inc. (AGIO)
2.83%
Nektar Therapeutics (NKTR)
2.79%
FibroGen Inc. (FGEN)
2.75%
Ultragenyx Pharmaceutical Inc. (RARE)
2.67%
Neurocrine Biosciences Inc. (NBIX)
2.34%
Intrexon Corporation (XON)
2.19%
First Trust NYSE Arca Biotechnology Index Fund (FBT)
0%

FBT Technicals

Alpha

-3.68

Beta

1.38

Leverage

Long

Standard Deviation

10.95

FBT Dividends

Dividend Date

2015-09-23

Latest Dividend

0.02

Annual Dividend

0

Annual Dividend Rate

0

Annual Dividend Yield

1.0E-5

FBT Performance

YTD Return

18.48%

1 Year Return

6.22%

3 Year Return

70.44%

5 Year Return

76.95%

10 Year Return

695.99%

FBT Related Articles